Finland

Polygenic scores add most to prediction where clinical risk is already low

Across 150 diseases in 900,000 UK Biobank and FinnGen participants, polygenic risk scores added most to clinical prediction in metabolic, cardiovascular, autoimmune and neurological disease, and their gains were consistently larger among those at lower clinical risk.